Latest Corporate News News

📅March 3, 2026 at 1:00 PM
Geopolitical tensions from Iran war drive energy M&A surge and market declines; biotech and banking sectors see major mergers amid volatility.
1

Iran War Accelerates Rise of 'Poly-National' Companies

Amid escalating Iran conflict, companies are regionalizing operations to counter energy price spikes and cyber threats, with taxpayers bearing costs. Oil prices rose 6% as Strait of Hormuz shut down, impacting 20% of global petroleum. Markets plunged: S&P futures down 1.87%, Europe and Asia indices over 2-7%.Source 1

2

Energy Security and AI Demand Fuel $110 Billion US M&A Surge

US M&A hit $110.1 billion in January 2026 across 846 deals, led by energy sector amid Middle East escalation and AI power needs. Devon Energy and Coterra Energy announced $58 billion 'merger of equals' creating shale titan. Trend emphasizes onshoring for resource security.Source 2

3

Devon Energy and Coterra Energy Merge in $58 Billion Deal

Following Chevron, Devon (DVN) and Coterra (CTRA) form 'Super Independent' shale giant valued at $58 billion. Deal responds to global conflict and energy demands. Executives prioritize scale for survival in volatile world.Source 2

4

Transocean and Valaris Complete $5.8 Billion Offshore Merger

Transocean (RIG) and Valaris (VAL) merged for $5.8 billion, creating dominance in deepwater projects in Guyana and Brazil. Smaller contractors struggle to compete. Reflects 'winner-takes-all' in offshore drilling amid energy crisis.Source 2

5

Candid Therapeutics Merges with Rallybio, Raises $505 Million

Candid Therapeutics, advancing T-cell engagers for autoimmune diseases, merges with Rallybio (RLYB); combined firm to trade as CDRX on Nasdaq. Concurrent private financing yields over $505 million. Expected to close mid-2026.Source 4

6

RAPT Therapeutics Acquisition by GSK Affiliate Nears Completion

93.36% of shares tendered at $58 each in GSK affiliate's offer; merger set for March 3, 2026. RAPT (NASDAQ: RAPT) will delist and become wholly-owned subsidiary, ending public reporting. No shareholder vote required.Source 5

7

Cornerstone Capital Bank Acquires Peoples Bank

Cornerstone Capital Bancorp completes acquisition of Peoples Bancorp, boosting assets to $3.4 billion. Strengthens Texas presence and nationwide mortgage services; branches operate as Peoples division. Leadership teams intact.Source 6

8

Abony Acquisition Corp. I Raises $230 Million in IPO

SPAC Abony Acquisition Corp. I completes $230 million IPO, targeting defense tech, computing, software, media firms valued $750M-$1.5B. DLA Piper advised on the offering. Focuses on mergers or asset acquisitions globally.Source 7

9

Global Markets Plunge on Geopolitical Tensions

Asian and European indices fall over 2% on March 3; Brent crude below $80, gold above $5300. S&P futures down 1.87%, Nikkei 3.06%, KOSPI 7.24%. Iran conflict escalates fears.Source 1Source 3

10

Wilson Sonsini Advises Candid on Patent Matters in Rallybio Merger

Firm handled patent issues for Candid Therapeutics in March 2 merger with Rallybio. Supports TCE therapeutics portfolio advancement. Part of broader legal support for biotech deal.Source 9

11

Eli Lilly CEO Skeptical of AI in Cancer Cure Efforts

Tech giants push AI for cancer solutions, but Eli Lilly CEO calls it 'not particularly good' at biology or chemistry. Highlighted in Fortune's CEO Daily amid market turmoil. Reflects biotech leadership views.Source 1

12

Anthropic's Claude Tops App Store Over OpenAI Boycott

Claude overtakes ChatGPT after users boycott OpenAI's $200M Pentagon deal. Tech shifts amid AI competition and defense contracts. Noted in corporate leadership roundup.Source 1